Study in Patients With Asthma

• Status: Completed
• Trial end date: 2005-12-01

Summary

The purpose of this study is to determine which dose of the investigational drug is the most safe and effective in the treatment of asthma compared to the control drug.

• Phase: Phase 2

Details

• Lead Sponsor: Dey
• Treatments: Formoterol Fumarate